Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Drug and Biotech Stocks
Biotech companies scored big in the third quarter
by William J. Storck
October 17, 2005
| A version of this story appeared in
Volume 83, Issue 42
| THIRD-QUARTER STOCK PRICEa | CHANGE FROM SECOND-QUARTER CLOSE | CHANGE FROM 2004 CLOSE | PRICE/ EARNINGS RATIOb | |||
| HIGH | LOW | CLOSE | ||||
| MAJOR PHARMACEUTICAL COMPANIES | ||||||
| Abbott Laboratories | $49.99 | $41.94 | $42.40 | -13.5% | -9.1% | 18.0 |
| Baxter International | 40.95 | 37.08 | 39.87 | 7.5 | 15.4 | 20.3 |
| Bristol-Myers Squibb | 25.27 | 23.97 | 24.06 | -3.7 | -6.1 | 14.8 |
| Eli Lilly & Co. | 57.26 | 52.52 | 53.52 | -3.9 | -5.7 | 19.2 |
| Johnson & Johnson | 65.18 | 61.94 | 63.28 | -2.6 | -0.2 | 18.9 |
| Merck | 31.95 | 27.21 | 27.21 | -11.7 | -15.3 | 10.5 |
| Pfizer | 27.60 | 24.80 | 24.97 | -9.5 | -7.1 | 11.7 |
| Schering-Plough | 22.45 | 18.48 | 21.05 | 10.4 | 0.8 | 100.2 |
| Wyeth | 46.51 | 44.00 | 46.27 | 4.0 | 8.6 | 15.8 |
| C&EN pharmaceuticalindex c (1992 = 100) | 367.5 | 350.0 | 351.4 | -3.1% | -2.0% | |
| Dow Jones industrialaverage | 10705.6 | 10270.7 | 10568.7 | 2.9% | -2.0% | |
| BIOPHARMACEUTICAL AND DRUG DISCOVERY COMPANIES | ||||||
| Amgen | 86.17 | 60.86 | 79.67 | 31.8 | 24.2 | 28.3 |
| Biogen Idec | 42.80 | 34.08 | 39.48 | 14.6 | -40.7 | 27.4 |
| Celera Genomics | 13.00 | 10.78 | 12.13 | 10.6 | -11.8 | def |
| Cephalon | 46.98 | 38.47 | 46.42 | 16.6 | -8.8 | 16.3 |
| Chiron | 44.34 | 34.96 | 43.65 | 25.1 | 31.0 | 128.4 |
| Cytogen | 5.41 | 3.68 | 4.04 | -22.8 | -64.9 | def |
| Genentech | 94.74 | 79.86 | 84.21 | 4.9 | 54.7 | 81.0 |
| Genzyme | 75.20 | 59.70 | 71.64 | 19.2 | 23.4 | 34.3 |
| Gilead Sciences | 48.76 | 40.99 | 48.76 | 10.8 | 39.4 | 39.0 |
| Icos | 27.77 | 21.14 | 27.62 | 30.5 | -2.3 | def |
| MedImmune | 33.65 | 26.79 | 33.65 | 25.9 | 24.1 | 129.4 |
| Millennium Pharmaceuticals | 11.09 | 9.14 | 9.33 | 0.6 | -23.1 | def |
| Protein Design Labs | 29.92 | 20.12 | 28.00 | 38.5 | 35.5 | def |
| Vertex Pharmaceuticals | 22.35 | 15.53 | 22.35 | 32.6 | 111.4 | def |
| Xoma | 1.94 | 1.41 | 1.76 | 4.8 | -32.1 | def |
| C&EN biopharmaceutical index d (1992 = 100) | 534.2 | 447.7 | 528.9 | 18.6% | 13.0% | |
| NASDAQ | 2218.2 | 2057.4 | 2151.7 | 4.6% | -1.1% | |
a Adjusted for stock splits.
b As of Sept. 30, 2005.
c Based on the average stock price for the nine drug companies listed.
d Based on the average stock price for the 15 biopharmaceutical companies listed.
def = deficit in previous four quarters.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter